A specific binding site for K+ channel openers in rat aorta

Area of Science:

• Pharmacology
• Cardiovascular Research
• Molecular Biology

Background:

• Potassium (K+) channel openers are a diverse group of drugs that relax smooth muscle by opening plasmalemmal K+ channels.
• The specific binding target for these chemically heterogeneous compounds, particularly whether they interact with a common site on the K+ channel, remains largely unknown.

Purpose of the Study:

• To develop a binding assay for K+ channel openers in vascular smooth muscle.
• To investigate whether different families of K+ channel openers bind to a common target.
• To explore the allosteric interaction between K+ channel openers and blockers.

Main Methods:

• Development of a novel binding assay using a tritiated K+ channel opener, [3H]P1075 (a pinacidil analogue).
• Utilizing endothelium-denuded rat aortic rings for binding studies.
• Conducting inhibition studies with various K+ channel openers and the blocker glibenclamide.

Main Results:

• The novel radioligand [3H]P1075 demonstrated high-affinity binding (KD = 6 +/- 1 nM) to vascular smooth muscle.
• Inhibition studies provided evidence that different classes of K+ channel openers bind to a shared molecular target.
• The binding site for glibenclamide, a K+ channel opener blocker, appears to be negatively allosterically coupled to the opener binding site.

Conclusions:

• A functional binding assay for K+ channel openers has been successfully established in vascular smooth muscle.
• The findings strongly suggest a common binding site for diverse K+ channel openers, supporting a unified mechanism of action.
• This assay provides a foundation for the biochemical characterization of the K+ channel opener drug receptor and its interaction with blockers.